Endocrine Abstracts

Background: The leading cause of visual impairment among individuals with diabetes is diabetic retinopathy. Hybrid closed-loop (HCL) therapy has revolutionised diabetes care, offering a more automated and precise approach to insulin delivery. However, these technologies can inadvertently marginalise individuals with disabilities, including those with visual impairment.Case: We present the case of a legally blind 70-year-old female with a 60-year history ...

A 47-year-old man attending with a history of Cushing’s disease in remission following transsphenoidal surgery in 2013 continued to experience resistant hypertension which warranted further investigation. Postoperatively he was prescribed hydrocortisone 10 mg twice daily and desmotab 0.2 mg nocte for ACTH deficiency and diabetes insipidus. Over the course of six years antihypertensive therapy escalated until he required five agents – ramipril 10 mg, amlodipine 10 mg,...